<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[zentiva Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/zentiva.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to zentiva]]></description>
	<s:counts start="0" returned="3" found="3" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Why Can't Sanofi Get That Zentiva Deal Done?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000204/why-cant-sanofi-get-that-zentiva-deal-done/]]></link>
		<description><![CDATA[The M&A chess match going on between Sanofi-Aventis and Zentiva, a Czech Republic-based generic drug maker, is fascinating because it seems that the tiny Czech company is the one in a position of strength. Sanofi's bid was rejected by Zentiva on Wednesday.    At first glance, it appears...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 05 Sep 2008 11:35:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/crown.html"><![CDATA[Crown]]></category>
		<category domain="http://resources.bnet.com/topic/zentiva.html"><![CDATA[Zentiva]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/balance+sheets.html"><![CDATA[Balance Sheets]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/financial+statements.html"><![CDATA[Financial Statements]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Sanofi strikes back in takeover battle for big Czech drug company]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200806/ai_n26681005]]></link>
		<description><![CDATA[PRAGUE AFP &#8212; Czech-based generic drugs giant Zentiva was at the heart of a takeover tussle Wednesday after French group Sanofi-Aventis struck back with an offer countering a bid by local financial concern PPF.  PPF, holding a 19.2 percent stake in Zentiva, which has substantial markets in Slovakia, Romania...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 18 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/europe.html"><![CDATA[Europe]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/prague.html"><![CDATA[Prague]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/slovakia.html"><![CDATA[Slovakia]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/zentiva.html"><![CDATA[Zentiva]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Czech pharma giant buys Turkish peer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200703/ai_n18657601]]></link>
		<description><![CDATA[PRAGUE AFP &#8212; The Czech Republic's biggest pharmaceutical company, Zentiva, said Monday that it had agreed to buy 75 percent of Turkey's biggest drug company Eczacibasi Generic Pharmaceuticals for 460 million euros (606.7 million dollars).  The Czech company, which already has plants in Slovakia and Romania, added that it...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 05 Mar 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/prague.html"><![CDATA[Prague]]></category>
		<category domain="http://resources.bnet.com/topic/turkey.html"><![CDATA[Turkey]]></category>
		<category domain="http://resources.bnet.com/topic/zentiva.html"><![CDATA[Zentiva]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
